Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 51407-558

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 51407-558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-557-01.jpg (51407 557 01)

This is a description of a medication in capsule form containing a mix of amphetamine derivatives, including dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. The total amount of amphetamine base in each capsule is 3.1 mg. It is an extended-release capsule and additional information can be found in the insert. The medication should be stored in a tightly sealed, light-resistant container at room temperature. The medication comes with a Medication Guide to be dispensed with each prescription. The product is marketed by GSMS, Incorporated and distributed by Lannett Company, Inc.*

FDA Label Image

51407-558-01.jpg (51407 558 01)

This text provides information about extended-release capsules containing a mixture of amphetamines such as Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. The total amount of amphetamine base equivalence in each capsule is 6.3 mg. The text also includes instructions for storage, dispensing, and prescribing information. It is suggested to store the medication between 20° to 25°C(68° to 77°F) with excursions allowed between 15° to 30°C (59° to 86°F). The medication guide for the patient is also provided. The product is marketed by GSMS, Incorporated in Camarillo, CA and distributed by Lannett Company, Inc. in Philadelphia, PA.*

FDA Label Image

51407-559-01.jpg (51407 559 01)

This text describes the composition and storage information for extended-release capsules containing dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate, with a total amphetamine base equivalence of 9.4 mg. It provides the manufacturer's and distributor's information along with the NDC code. Pharmacists are advised to dispense with a medication guide to each patient. The text also provides storage instructions and recommends dispensing the capsules in a tight, light-resistant container as defined in the USP.*

FDA Label Image

51407-560-01.jpg (51407 560 01)

This is a medication guide for Extended-Release Capsules containing Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. It is manufactured by GSMS, Incorporated and distributed by Lannett Company, Inc. Each capsule contains a total of 12.5 mg amphetamine base equivalence. Storage should be at 20° to 25°C (68° to 77°F) and dispensed in a tight, light-resistant container as defined in the USP. For full information, refer to the package insert. Pharmacists should dispense with a medication guide for each patient.*

FDA Label Image

51407-561-01.jpg (51407 561 01)

This is a medication with each extended-release capsule containing a mixture of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. The total amphetamine base equivalence is 15.6 mg. The medication should be stored at 20° to 25°C (68° to 77°F) and tightly sealed in a light-resistant container. Dispensing should include a medication guide to the patient. More information about the medication can be found in the package insert. It is distributed by Lonnett Company, Inc. in Philadelphia and marketed by GSMS, Incorporated in Camarillo, CA.*

FDA Label Image

51407-562-01.jpg (51407 562 01)

This is a medication in the form of extended-release capsules containing a combination of four amphetamine salts. The total equivalent amount of amphetamine base is 18.8 mg. It is prescribed for various conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. The package insert should be consulted for complete information about the medication. It should be stored in a tightly sealed, light-resistant container at controlled room temperature. The medication is distributed by Lannett Company Inc. and manufactured by GSMS Incorporated. A medication guide should be provided with each patient, which can be printed from the website provided.*

FDA Label Image

Figure (Dextroamphetamine Saccharate Amphetamine Aspartate 1)

This appears to be a graph displaying the mean plasmia concentrations of Dextro and Levoamphetamine over time. Different formulations of Dextro and Levoamphetamine are listed with corresponding dosages and release mechanisms. The x-axis shows time in hours and the y-axis shows the concentration of the drugs in the plasma.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.